Related News
Sanofi sees mainland sales grow 8.8% in 2014
Print Edition
FRENCH pharmaceutical giant Sanofi said sales in China’s mainland grew 8.8 percent last year due to strong sales of cardiovascular and diabetes drugs.
The mainland’s sales growth nearly doubled the global increase of 4.9 percent.
Mainland sales were worth 1.6 billion euros (US$1.8 billion), compared with the global figure of 33.8 billion euros.
Sanofi hopes to continue to increase its market share for diabetes drugs and vaccine business as one of its main business growth engines in the coming year, Jean-Luc Lowinski, senior vice president of Sanofi Asia and president of Sanofi China, told a media briefing in Shanghai.
The company will also expand into lower-tier cities and counties by offering high-quality generic drugs at affordable prices, and Lowinski said Sanofi is open to discussions about launching new OTC products by collaborating with domestic drug companies.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
